CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Curaleaf Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026
- Market cap
- $2.07B
- P/E (TTM)
- –
- Dividend yield
- –
Curaleaf statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Curaleaf | Industry median |
|---|---|---|
| Market Cap | $2.02B | $164.85M |
| Enterprise Value | $2.54B | $87.06M |
| PS Ratio | 1.59 | 3.60 |
| PB Ratio | 2.33 | 2.03 |
| P/FCF Ratio | 27.21 | 17.44 |
| P/OCF Ratio | 14.67 | 13.32 |
Enterprise value
| Measure | Curaleaf | Industry median |
|---|---|---|
| EV / Sales | 2.00 | 2.43 |
| EV / EBITDA | 11.43 | 14.69 |
| EV / EBIT | 99.70 | 18.47 |
| EV / FCF | 34.17 | 20.97 |
Income (trailing twelve months)
| Measure | Curaleaf | Industry median |
|---|---|---|
| Revenue | $1.27B | $57.94M |
| Gross Profit | $631.02M | $90.47M |
| Operating Income | $25.45M | -$21.44M |
| Pretax Income | -$78.21M | -$14.45M |
| Net Income | -$231.07M | -$22.46M |
| EBITDA | $222.06M | -$16.91M |
| EPS (Diluted) | -$1.05 | -$0.83 |
Margins
| Measure | Curaleaf | Industry median |
|---|---|---|
| Gross Margin | 49.8% | 52.3% |
| Operating Margin | 2.01% | -44.5% |
| Pretax Margin | -6.17% | -13.0% |
| Profit Margin | -18.2% | -39.2% |
| EBITDA Margin | 17.5% | -31.3% |
| FCF Margin | 5.86% | -8.85% |
Returns
| Measure | Curaleaf | Industry median |
|---|---|---|
| Return on Equity (ROE) | -26.6% | -53.1% |
| Return on Assets (ROA) | -8.21% | -41.0% |
| Return on Invested Capital (ROIC) | 1.85% | -32.0% |
| Return on Capital Employed (ROCE) | 1.02% | -37.8% |
Growth
| Measure | Curaleaf | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -4.96% | 6.01% |
| FCF Growth (YoY) | 4.33% | 2.34% |
| Revenue Growth (3Y CAGR) | -0.19% | 2.25% |
| Revenue Growth (5Y CAGR) | 15.1% | 6.42% |
Balance sheet
| Measure | Curaleaf | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $94.59M | $62.42M |
| Total Debt | $611.54M | $120.13M |
| Net Cash (Debt) | -$516.95M | $15.68M |
| Net Cash Per Share | -$1.95 | $0.66 |
| Equity (Book Value) | $867.46M | $48.79M |
| Book Value Per Share | $3.28 | $1.36 |
| Tangible Book Value | -$721.64M | $23.06M |
| Working Capital | $160.68M | $75.77M |
Financial position
| Measure | Curaleaf | Industry median |
|---|---|---|
| Current Ratio | 1.52 | 3.30 |
| Quick Ratio | 0.54 | 2.39 |
| Debt / Equity | 0.70 | 0.51 |
| Debt / EBITDA | 2.75 | 3.35 |
| Debt / FCF | 8.23 | 5.05 |
| Net Debt / EBITDA | 2.33 | 2.22 |
| Interest Coverage | 0.48 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Curaleaf | Industry median |
|---|---|---|
| Operating Cash Flow | $137.71M | -$12.35M |
| Capital Expenditures | -$63.44M | -$1.06M |
| Free Cash Flow | $74.27M | -$20.28M |
| FCF Per Share | $0.28 | -$0.42 |
Efficiency
| Measure | Curaleaf | Industry median |
|---|---|---|
| Asset Turnover | 0.45 | 0.38 |
| Inventory Turnover | 2.60 | 2.67 |
Dividends and yields
| Measure | Curaleaf | Industry median |
|---|---|---|
| Earnings Yield | -11.4% | -22.7% |
| FCF Yield | 3.68% | -9.07% |
Shares
| Measure | Curaleaf | Industry median |
|---|---|---|
| Shares Outstanding | 264,808,000 | 58,179,650 |
| Shares Change (YoY) | 2.87% | 11.1% |
| Float | 264,808,000 | 49,173,100 |
| Shares Held by Insiders | 0.00% | 11.6% |
| Shares Held by Institutions | 4.70% | 59.4% |
Taxes
| Measure | Curaleaf | Industry median |
|---|---|---|
| Income Tax | $123.69M | $91.50K |
Scores
| Measure | Curaleaf | Industry median |
|---|---|---|
| Altman Z-Score | 0.42 | -0.24 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -2.95 | -2.62 |
Calculated by StockData from Curaleaf's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.